Tianqi Pingchan Granule

also known as TPG

Developed for: drug-induced dyskinesia
Investigated by: Affiliated Hospital of Nanjing University of Chinese Medicine · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine · Huai'an First People's Hospital · Shanghai Municipal Hospital of Traditional Chinese Medicine · Shanghai University of Traditional Chinese Medicine · Suqian Branch, Jiangsu Province Hospital
+4 more
· The Affiliated Hospital of Qingdao University · The Affiliated Hospital of Xuzhou Medical University · Wenzhou Central Hospital · Xin Hua Hospital of Zhejiang Province

2020202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
—	NCT04173832	Jan → Dec 2020	drug-induced dyskinesia	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine	Unknown	Met primary
—	NCT04173845	Sep 2019 → Dec 2020	drug-induced dyskinesia	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 3 sources stand behind the page.

Field	Value	Cited text
Known as	Tianqi Pingchan Granule	ClinicalTrials.gov intervention name — accepted as the source's own label NCT04173845 ↗ 1 NCT04173832 ↗
Known as	TPG	“Tianqi Pingchan Granule (TPG), a compound Chinese herbal medicine, has been developed to relieve symptom of LID.” PMID 39060125 ↗ Jul 2024
Modality	Traditional medicine (herbal / TCM)	“Tianqi Pingchan Granule (TPG), a compound Chinese herbal medicine” PMID 39060125 ↗ Jul 2024
Route	Oral	“12-week period of oral treatment with Tianqi Pingchan Granule Combined With Amantadine” NCT04173832 ↗